The patient with Parkinson’s disease: Part I–Treating the motor symptoms;Part II–Treating the nonmotor symptoms
Identifieur interne : 000200 ( Istex/Corpus ); précédent : 000199; suivant : 000201The patient with Parkinson’s disease: Part I–Treating the motor symptoms;Part II–Treating the nonmotor symptoms
Auteurs : Charlene Hoffman Snyder ; Charles H. AdlerSource :
- Journal of the American Academy of Nurse Practitioners [ 1041-2972 ] ; 2007-04.
English descriptors
- KwdEn :
Abstract
Purpose: This two‐part article provides the nurse practitioner (NP) with information on the developments in the pathophysiology and expanded treatment options in the motor and nonmotor symptoms of Parkinson’s disease (PD). The discussion provides treatment strategies that may offer improved ability to manage the disabling symptoms of this neurodegenerative disorder.
Data sources: Review of scientific literature from PubMed search for English language articles on PD from 1998 to 2005 and books or chapters in textbooks published on the disease in the same time frame provided the data source for this article. The content reflects our clinical judgments and experience from clinical practice in the Movement Disorder Clinic at Mayo Clinic Arizona.
Conclusions: The high prevalence of the disease and important advances in its management means that the NP needs to have knowledge of the disorder and the combination of multiple treatment options available for both the motor and the nonmotor symptoms.
Implications for practice: PD is a progressive neurodegenerative disease affecting 1% of persons over the age of 60 in the United States. As prevalence increases with age, so does the need for early accurate diagnosis and proper treatment of the PD by the clinician. Advances in the treatment for the motor and nonmotor symptoms of PD provide the clinician with increased options to improve the patient’s quality of life.
Url:
DOI: 10.1111/j.1745-7599.2007.00211.x
Links to Exploration step
ISTEX:012A91DF64309F5463471B5D0FFE178E4A4962EBLe document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">The patient with Parkinson’s disease: Part I–Treating the motor symptoms;Part II–Treating the nonmotor symptoms</title><author><name sortKey="Snyder, Charlene Hoffman" sort="Snyder, Charlene Hoffman" uniqKey="Snyder C" first="Charlene Hoffman" last="Snyder">Charlene Hoffman Snyder</name><affiliation><mods:affiliation>Department of Neurology, Mayo Clinic Arizona, Scottsdale, Arizona</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: snyder.charlene@mayo.edu</mods:affiliation></affiliation></author><author><name sortKey="Adler, Charles H" sort="Adler, Charles H" uniqKey="Adler C" first="Charles H." last="Adler">Charles H. Adler</name><affiliation><mods:affiliation>Department of Neurology, Mayo Clinic Arizona, Scottsdale, Arizona</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:012A91DF64309F5463471B5D0FFE178E4A4962EB</idno><date when="2007" year="2007">2007</date><idno type="doi">10.1111/j.1745-7599.2007.00211.x</idno><idno type="url">https://api.istex.fr/document/012A91DF64309F5463471B5D0FFE178E4A4962EB/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">000200</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000200</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">The patient with Parkinson’s disease: Part I–Treating the motor symptoms;Part II–Treating the nonmotor symptoms</title><author><name sortKey="Snyder, Charlene Hoffman" sort="Snyder, Charlene Hoffman" uniqKey="Snyder C" first="Charlene Hoffman" last="Snyder">Charlene Hoffman Snyder</name><affiliation><mods:affiliation>Department of Neurology, Mayo Clinic Arizona, Scottsdale, Arizona</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: snyder.charlene@mayo.edu</mods:affiliation></affiliation></author><author><name sortKey="Adler, Charles H" sort="Adler, Charles H" uniqKey="Adler C" first="Charles H." last="Adler">Charles H. Adler</name><affiliation><mods:affiliation>Department of Neurology, Mayo Clinic Arizona, Scottsdale, Arizona</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Journal of the American Academy of Nurse Practitioners</title><idno type="ISSN">1041-2972</idno><idno type="eISSN">1745-7599</idno><imprint><publisher>Blackwell Publishing Inc</publisher><pubPlace>Malden, USA</pubPlace><date type="published" when="2007-04">2007-04</date><biblScope unit="volume">19</biblScope><biblScope unit="issue">4</biblScope><biblScope unit="page" from="179">179</biblScope><biblScope unit="page" to="197">197</biblScope></imprint><idno type="ISSN">1041-2972</idno></series><idno type="istex">012A91DF64309F5463471B5D0FFE178E4A4962EB</idno><idno type="DOI">10.1111/j.1745-7599.2007.00211.x</idno><idno type="ArticleID">JAAN211</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">1041-2972</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Lewy bodies</term><term>Parkinson’s disease</term><term>amantadine</term><term>anticholinergics</term><term>bradykinesia</term><term>catechol‐O‐methyltransferase inhibitors</term><term>deep brain stimulation</term><term>dopamine agonists</term><term>dyskinesias</term><term>freezing</term><term>levodopa</term><term>monamine oxidase inhibitors</term><term>motor symptoms</term><term>parkinsonism</term><term>postural instability</term><term>rigidity</term><term>tremor</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract">Purpose: This two‐part article provides the nurse practitioner (NP) with information on the developments in the pathophysiology and expanded treatment options in the motor and nonmotor symptoms of Parkinson’s disease (PD). The discussion provides treatment strategies that may offer improved ability to manage the disabling symptoms of this neurodegenerative disorder.</div><div type="abstract">Data sources: Review of scientific literature from PubMed search for English language articles on PD from 1998 to 2005 and books or chapters in textbooks published on the disease in the same time frame provided the data source for this article. The content reflects our clinical judgments and experience from clinical practice in the Movement Disorder Clinic at Mayo Clinic Arizona.</div><div type="abstract">Conclusions: The high prevalence of the disease and important advances in its management means that the NP needs to have knowledge of the disorder and the combination of multiple treatment options available for both the motor and the nonmotor symptoms.</div><div type="abstract">Implications for practice: PD is a progressive neurodegenerative disease affecting 1% of persons over the age of 60 in the United States. As prevalence increases with age, so does the need for early accurate diagnosis and proper treatment of the PD by the clinician. Advances in the treatment for the motor and nonmotor symptoms of PD provide the clinician with increased options to improve the patient’s quality of life.</div></front></TEI><istex><corpusName>wiley</corpusName><author><json:item><name>Charlene Hoffman Snyder MSN, NP‐BC</name><affiliations><json:string>Department of Neurology, Mayo Clinic Arizona, Scottsdale, Arizona</json:string><json:string>E-mail: snyder.charlene@mayo.edu</json:string></affiliations></json:item><json:item><name>Charles H. Adler MD, PhD</name><affiliations><json:string>Department of Neurology, Mayo Clinic Arizona, Scottsdale, Arizona</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>Parkinson’s disease</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>Lewy bodies</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>parkinsonism</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>dyskinesias</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>tremor</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>rigidity</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>bradykinesia</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>freezing</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>postural instability</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>motor symptoms</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>levodopa</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>dopamine agonists</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>monamine oxidase inhibitors</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>catechol‐O‐methyltransferase inhibitors</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>amantadine</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>anticholinergics</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>deep brain stimulation</value></json:item></subject><articleId><json:string>JAAN211</json:string></articleId><language><json:string>eng</json:string></language><originalGenre><json:string>article</json:string></originalGenre><qualityIndicators><score>5.6</score><pdfVersion>1.3</pdfVersion><pdfPageSize>585 x 783 pts</pdfPageSize><refBibsNative>true</refBibsNative><abstractCharCount>368</abstractCharCount><pdfWordCount>11670</pdfWordCount><pdfCharCount>76845</pdfCharCount><pdfPageCount>19</pdfPageCount><abstractWordCount>50</abstractWordCount></qualityIndicators><title>The patient with Parkinson’s disease: Part I–Treating the motor symptoms;Part II–Treating the nonmotor symptoms</title><genre><json:string>article</json:string></genre><host><volume>19</volume><publisherId><json:string>JAAN</json:string></publisherId><pages><total>19</total><last>197</last><first>179</first></pages><issn><json:string>1041-2972</json:string></issn><issue>4</issue><genre><json:string>journal</json:string></genre><language><json:string>unknown</json:string></language><eissn><json:string>1745-7599</json:string></eissn><title>Journal of the American Academy of Nurse Practitioners</title><doi><json:string>10.1111/(ISSN)1745-7599</json:string></doi></host><categories><wos><json:string>social science</json:string><json:string>nursing</json:string><json:string>science</json:string><json:string>health care sciences & services</json:string></wos><scienceMetrix><json:string>health sciences</json:string><json:string>public health & health services</json:string><json:string>nursing</json:string></scienceMetrix></categories><publicationDate>2007</publicationDate><copyrightDate>2007</copyrightDate><doi><json:string>10.1111/j.1745-7599.2007.00211.x</json:string></doi><id>012A91DF64309F5463471B5D0FFE178E4A4962EB</id><score>0.22114865</score><fulltext><json:item><extension>pdf</extension><original>true</original><mimetype>application/pdf</mimetype><uri>https://api.istex.fr/document/012A91DF64309F5463471B5D0FFE178E4A4962EB/fulltext/pdf</uri></json:item><json:item><extension>zip</extension><original>false</original><mimetype>application/zip</mimetype><uri>https://api.istex.fr/document/012A91DF64309F5463471B5D0FFE178E4A4962EB/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/012A91DF64309F5463471B5D0FFE178E4A4962EB/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a" type="main" xml:lang="en">The patient with Parkinson’s disease: Part I–Treating the motor symptoms;Part II–Treating the nonmotor symptoms</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>Blackwell Publishing Inc</publisher><pubPlace>Malden, USA</pubPlace><availability><p>2007 American Academy of Nurse Practitioners</p></availability><date>2007</date></publicationStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a" type="main" xml:lang="en">The patient with Parkinson’s disease: Part I–Treating the motor symptoms;Part II–Treating the nonmotor symptoms</title><author xml:id="author-1"><persName><forename type="first">Charlene Hoffman</forename><surname>Snyder</surname></persName><roleName type="degree">MSN, NP‐BC</roleName><email>snyder.charlene@mayo.edu</email><note type="biography">(Nurse Practitioner and Instructor)</note><affiliation>(Nurse Practitioner and Instructor)</affiliation><affiliation>Department of Neurology, Mayo Clinic Arizona, Scottsdale, Arizona</affiliation></author><author xml:id="author-2"><persName><forename type="first">Charles H.</forename><surname>Adler</surname></persName><roleName type="degree">MD, PhD</roleName><note type="biography">(Professor)</note><affiliation>(Professor)</affiliation><affiliation>Department of Neurology, Mayo Clinic Arizona, Scottsdale, Arizona</affiliation></author></analytic><monogr><title level="j">Journal of the American Academy of Nurse Practitioners</title><idno type="pISSN">1041-2972</idno><idno type="eISSN">1745-7599</idno><idno type="DOI">10.1111/(ISSN)1745-7599</idno><imprint><publisher>Blackwell Publishing Inc</publisher><pubPlace>Malden, USA</pubPlace><date type="published" when="2007-04"></date><biblScope unit="volume">19</biblScope><biblScope unit="issue">4</biblScope><biblScope unit="page" from="179">179</biblScope><biblScope unit="page" to="197">197</biblScope></imprint></monogr><idno type="istex">012A91DF64309F5463471B5D0FFE178E4A4962EB</idno><idno type="DOI">10.1111/j.1745-7599.2007.00211.x</idno><idno type="ArticleID">JAAN211</idno></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>2007</date></creation><langUsage><language ident="en">en</language></langUsage><abstract><p>Purpose: This two‐part article provides the nurse practitioner (NP) with information on the developments in the pathophysiology and expanded treatment options in the motor and nonmotor symptoms of Parkinson’s disease (PD). The discussion provides treatment strategies that may offer improved ability to manage the disabling symptoms of this neurodegenerative disorder.</p></abstract><abstract><p>Data sources: Review of scientific literature from PubMed search for English language articles on PD from 1998 to 2005 and books or chapters in textbooks published on the disease in the same time frame provided the data source for this article. The content reflects our clinical judgments and experience from clinical practice in the Movement Disorder Clinic at Mayo Clinic Arizona.</p></abstract><abstract><p>Conclusions: The high prevalence of the disease and important advances in its management means that the NP needs to have knowledge of the disorder and the combination of multiple treatment options available for both the motor and the nonmotor symptoms.</p></abstract><abstract><p>Implications for practice: PD is a progressive neurodegenerative disease affecting 1% of persons over the age of 60 in the United States. As prevalence increases with age, so does the need for early accurate diagnosis and proper treatment of the PD by the clinician. Advances in the treatment for the motor and nonmotor symptoms of PD provide the clinician with increased options to improve the patient’s quality of life.</p></abstract><textClass xml:lang="en"><keywords scheme="keyword"><list><head>keywords</head><item><term>Parkinson’s disease</term></item><item><term>Lewy bodies</term></item><item><term>parkinsonism</term></item><item><term>dyskinesias</term></item><item><term>tremor</term></item><item><term>rigidity</term></item><item><term>bradykinesia</term></item><item><term>freezing</term></item><item><term>postural instability</term></item><item><term>motor symptoms</term></item><item><term>levodopa</term></item><item><term>dopamine agonists</term></item><item><term>monamine oxidase inhibitors</term></item><item><term>catechol‐O‐methyltransferase inhibitors</term></item><item><term>amantadine</term></item><item><term>anticholinergics</term></item><item><term>deep brain stimulation</term></item></list></keywords></textClass></profileDesc><revisionDesc><change when="2007-04">Published</change></revisionDesc></teiHeader></istex:fulltextTEI><json:item><extension>txt</extension><original>false</original><mimetype>text/plain</mimetype><uri>https://api.istex.fr/document/012A91DF64309F5463471B5D0FFE178E4A4962EB/fulltext/txt</uri></json:item></fulltext><metadata><istex:metadataXml wicri:clean="Wiley, elements deleted: body"><istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration><istex:document><component version="2.0" type="serialArticle" xml:lang="en"><header><publicationMeta level="product"><publisherInfo><publisherName>Blackwell Publishing Inc</publisherName><publisherLoc>Malden, USA</publisherLoc></publisherInfo><doi origin="wiley" registered="yes">10.1111/(ISSN)1745-7599</doi><issn type="print">1041-2972</issn><issn type="electronic">1745-7599</issn><idGroup><id type="product" value="JAAN"></id><id type="publisherDivision" value="ST"></id></idGroup><titleGroup><title type="main" sort="JOURNAL OF AMERICAN ACADEMY NURSE PRACTITIONERS">Journal of the American Academy of Nurse Practitioners</title></titleGroup></publicationMeta><publicationMeta level="part" position="04004"><doi origin="wiley">10.1111/jaan.2007.19.issue-4</doi><numberingGroup><numbering type="journalVolume" number="19">19</numbering><numbering type="journalIssue" number="4">4</numbering></numberingGroup><coverDate startDate="2007-04">April 2007</coverDate></publicationMeta><publicationMeta level="unit" type="article" position="3" status="forIssue"><doi origin="wiley">10.1111/j.1745-7599.2007.00211.x</doi><idGroup><id type="unit" value="JAAN211"></id></idGroup><countGroup><count type="pageTotal" number="19"></count></countGroup><titleGroup><title type="tocHeading1">PRACTICE</title></titleGroup><copyright>2007 American Academy of Nurse Practitioners</copyright><eventGroup><event type="firstOnline" date="2007-04-06"></event><event type="publishedOnlineFinalForm" date="2007-04-06"></event><event type="xmlConverted" agent="Converter:BPG_TO_WML3G version:2.3.6 mode:FullText source:HeaderRef result:HeaderRef" date="2010-04-20"></event><event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-01-28"></event><event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-30"></event></eventGroup><numberingGroup><numbering type="pageFirst" number="179">179</numbering><numbering type="pageLast" number="197">197</numbering></numberingGroup><correspondenceTo>Charlene Hoffman Snyder, MSN, NP‐BC, Department of Neurology, Mayo Clinic Arizona, 13400 East Shea Boulevard, Scottsdale, AZ 85259.
Tel: 480‐301‐8100; Fax: 480‐301‐8451;
E‐mail: <email>snyder.charlene@mayo.edu</email></correspondenceTo><linkGroup><link type="toTypesetVersion" href="file:JAAN.JAAN211.pdf"></link></linkGroup></publicationMeta><contentMeta><unparsedEditorialHistory>Received: March 2006; accepted: April 2006</unparsedEditorialHistory><countGroup><count type="figureTotal" number="0"></count><count type="tableTotal" number="7"></count><count type="formulaTotal" number="0"></count><count type="referenceTotal" number="79"></count><count type="wordTotal" number="0"></count><count type="linksPubMed" number="0"></count><count type="linksCrossRef" number="0"></count></countGroup><titleGroup><title type="main">The patient with Parkinson’s disease: Part I–Treating the motor symptoms;
Part II–Treating the nonmotor symptoms</title><title type="shortAuthors">C.H. Snyder & C.H. Adler</title><title type="short">Motor symptoms of PD</title></titleGroup><creators><creator creatorRole="author" xml:id="cr1" affiliationRef="#a1" corresponding="yes"><personName><givenNames>Charlene Hoffman</givenNames><familyName>Snyder</familyName><degrees>MSN, NP‐BC</degrees></personName><jobTitle>(Nurse Practitioner and Instructor)</jobTitle></creator><creator creatorRole="author" xml:id="cr2" affiliationRef="#a1"><personName><givenNames>Charles H.</givenNames><familyName>Adler</familyName><degrees>MD, PhD</degrees></personName><jobTitle>(Professor)</jobTitle></creator></creators><affiliationGroup><affiliation xml:id="a1" countryCode="US"><unparsedAffiliation>Department of Neurology, Mayo Clinic Arizona, Scottsdale, Arizona</unparsedAffiliation></affiliation></affiliationGroup><keywordGroup xml:lang="en"><keyword xml:id="k1">Parkinson’s disease</keyword><keyword xml:id="k2">Lewy bodies</keyword><keyword xml:id="k3">parkinsonism</keyword><keyword xml:id="k4">dyskinesias</keyword><keyword xml:id="k5">tremor</keyword><keyword xml:id="k6">rigidity</keyword><keyword xml:id="k7">bradykinesia</keyword><keyword xml:id="k8">freezing</keyword><keyword xml:id="k9">postural instability</keyword><keyword xml:id="k10">motor symptoms</keyword><keyword xml:id="k11">levodopa</keyword><keyword xml:id="k12">dopamine agonists</keyword><keyword xml:id="k13">monamine oxidase inhibitors</keyword><keyword xml:id="k14">catechol‐O‐methyltransferase inhibitors</keyword><keyword xml:id="k15">amantadine</keyword><keyword xml:id="k16">anticholinergics</keyword><keyword xml:id="k17">deep brain stimulation</keyword></keywordGroup><abstractGroup><abstract type="main" xml:lang="en"><title type="main">Abstract</title><p><b>Purpose: </b> This two‐part article provides the nurse practitioner (NP) with information on the developments in the pathophysiology and expanded treatment options in the motor and nonmotor symptoms of Parkinson’s disease (PD). The discussion provides treatment strategies that may offer improved ability to manage the disabling symptoms of this neurodegenerative disorder.</p><p><b>Data sources: </b> Review of scientific literature from PubMed search for English language articles on PD from 1998 to 2005 and books or chapters in textbooks published on the disease in the same time frame provided the data source for this article. The content reflects our clinical judgments and experience from clinical practice in the Movement Disorder Clinic at Mayo Clinic Arizona.</p><p><b>Conclusions: </b> The high prevalence of the disease and important advances in its management means that the NP needs to have knowledge of the disorder and the combination of multiple treatment options available for both the motor and the nonmotor symptoms.</p><p><b>Implications for practice: </b> PD is a progressive neurodegenerative disease affecting 1% of persons over the age of 60 in the United States. As prevalence increases with age, so does the need for early accurate diagnosis and proper treatment of the PD by the clinician. Advances in the treatment for the motor and nonmotor symptoms of PD provide the clinician with increased options to improve the patient’s quality of life.</p></abstract></abstractGroup></contentMeta></header></component></istex:document></istex:metadataXml><mods version="3.6"><titleInfo lang="en"><title>The patient with Parkinson’s disease: Part I–Treating the motor symptoms;Part II–Treating the nonmotor symptoms</title></titleInfo><titleInfo type="abbreviated" lang="en"><title>Motor symptoms of PD</title></titleInfo><titleInfo type="alternative" contentType="CDATA" lang="en"><title>The patient with Parkinson’s disease: Part I–Treating the motor symptoms;
Part II–Treating the nonmotor symptoms</title></titleInfo><name type="personal"><namePart type="given">Charlene Hoffman</namePart><namePart type="family">Snyder</namePart><namePart type="termsOfAddress">MSN, NP‐BC</namePart><affiliation>Department of Neurology, Mayo Clinic Arizona, Scottsdale, Arizona</affiliation><affiliation>E-mail: snyder.charlene@mayo.edu</affiliation><role><roleTerm type="text">author</roleTerm></role><description>(Nurse Practitioner and Instructor)</description></name><name type="personal"><namePart type="given">Charles H.</namePart><namePart type="family">Adler</namePart><namePart type="termsOfAddress">MD, PhD</namePart><affiliation>Department of Neurology, Mayo Clinic Arizona, Scottsdale, Arizona</affiliation><role><roleTerm type="text">author</roleTerm></role><description>(Professor)</description></name><typeOfResource>text</typeOfResource><genre type="article" displayLabel="article"></genre><originInfo><publisher>Blackwell Publishing Inc</publisher><place><placeTerm type="text">Malden, USA</placeTerm></place><dateIssued encoding="w3cdtf">2007-04</dateIssued><edition>Received: March 2006; accepted: April 2006</edition><copyrightDate encoding="w3cdtf">2007</copyrightDate></originInfo><language><languageTerm type="code" authority="rfc3066">en</languageTerm><languageTerm type="code" authority="iso639-2b">eng</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType><extent unit="tables">7</extent><extent unit="references">79</extent></physicalDescription><abstract>Purpose: This two‐part article provides the nurse practitioner (NP) with information on the developments in the pathophysiology and expanded treatment options in the motor and nonmotor symptoms of Parkinson’s disease (PD). The discussion provides treatment strategies that may offer improved ability to manage the disabling symptoms of this neurodegenerative disorder.</abstract><abstract>Data sources: Review of scientific literature from PubMed search for English language articles on PD from 1998 to 2005 and books or chapters in textbooks published on the disease in the same time frame provided the data source for this article. The content reflects our clinical judgments and experience from clinical practice in the Movement Disorder Clinic at Mayo Clinic Arizona.</abstract><abstract>Conclusions: The high prevalence of the disease and important advances in its management means that the NP needs to have knowledge of the disorder and the combination of multiple treatment options available for both the motor and the nonmotor symptoms.</abstract><abstract>Implications for practice: PD is a progressive neurodegenerative disease affecting 1% of persons over the age of 60 in the United States. As prevalence increases with age, so does the need for early accurate diagnosis and proper treatment of the PD by the clinician. Advances in the treatment for the motor and nonmotor symptoms of PD provide the clinician with increased options to improve the patient’s quality of life.</abstract><subject lang="en"><genre>keywords</genre><topic>Parkinson’s disease</topic><topic>Lewy bodies</topic><topic>parkinsonism</topic><topic>dyskinesias</topic><topic>tremor</topic><topic>rigidity</topic><topic>bradykinesia</topic><topic>freezing</topic><topic>postural instability</topic><topic>motor symptoms</topic><topic>levodopa</topic><topic>dopamine agonists</topic><topic>monamine oxidase inhibitors</topic><topic>catechol‐O‐methyltransferase inhibitors</topic><topic>amantadine</topic><topic>anticholinergics</topic><topic>deep brain stimulation</topic></subject><relatedItem type="host"><titleInfo><title>Journal of the American Academy of Nurse Practitioners</title></titleInfo><genre type="journal">journal</genre><identifier type="ISSN">1041-2972</identifier><identifier type="eISSN">1745-7599</identifier><identifier type="DOI">10.1111/(ISSN)1745-7599</identifier><identifier type="PublisherID">JAAN</identifier><part><date>2007</date><detail type="volume"><caption>vol.</caption><number>19</number></detail><detail type="issue"><caption>no.</caption><number>4</number></detail><extent unit="pages"><start>179</start><end>197</end><total>19</total></extent></part></relatedItem><identifier type="istex">012A91DF64309F5463471B5D0FFE178E4A4962EB</identifier><identifier type="DOI">10.1111/j.1745-7599.2007.00211.x</identifier><identifier type="ArticleID">JAAN211</identifier><accessCondition type="use and reproduction" contentType="copyright">2007 American Academy of Nurse Practitioners</accessCondition><recordInfo><recordContentSource>WILEY</recordContentSource><recordOrigin>Blackwell Publishing Inc</recordOrigin></recordInfo></mods></metadata><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Psychologie/explor/DanceTherParkinsonV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000200 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 000200 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Psychologie
|area= DanceTherParkinsonV1
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:012A91DF64309F5463471B5D0FFE178E4A4962EB
|texte= The patient with Parkinson’s disease: Part I–Treating the motor symptoms;Part II–Treating the nonmotor symptoms
}}
| This area was generated with Dilib version V0.6.35. |  |